Nealbarbital

Nealbarbital

Clinical data
Other names	Nealbarbital, Censedal
ATC code	none
Identifiers
IUPAC name 5-allyl-5-(1,1-dimethylpropyl)pyrimidine-2,4,6(1H,3H,5H)-trione
CAS Number	561-83-1  Y
PubChem CID	521716
ChemSpider	455089  Y
UNII	25ATP958PA
CompTox Dashboard (EPA)	DTXSID70871769
ECHA InfoCard	100.008.386
Chemical and physical data
Formula	C12H18N2O3
Molar mass	238.287 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C1NC(=O)NC(=O)C1(CC(C)(C)C)C\C=C
InChI InChI=1S/C12H18N2O3/c1-5-6-12(7-11(2,3)4)8(15)13-10(17)14-9(12)16/h5H,1,6-7H2,2-4H3,(H2,13,14,15,16,17) Y Key:YHKPTICJRUESOY-UHFFFAOYSA-N Y
(verify)

Nealbarbital (Censedal) is a barbiturate derivative developed by Aktiebolaget Pharmacia in the 1950s. ^[1] It has sedative and hypnotic effects, and was used for the treatment of insomnia. ^[2]

References

1. US 2899435,Brändström AE,"S-neopentyl s-aixyl barbituric acid",issued 11 August 1959, assigned to Aktiebolaget Pharmacia 
2. Robin AA, Enoch MD (November 1964). "A Validation Study of Nealbarbital". The British Journal of Psychiatry. 110: 855–858. doi:10.1192/bjp.110.469.855. PMID   14211704.